Cellectis S.A.
Cellectis S.A. (CMVLF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · CMVLF · as of Jun 9, 2026
Key Statistics
Explore Cellectis S.A. Data
cmvlf stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 10 · Buy rate: 70.0%
Competitors & Peers
cmvlf competitorsCMVLF
CLVLF
CYDY
FGHQF
HLOSF
HNSBFStock Performance
Full HistoryAbout Cellectis S.A.
Cellectis S.A. is a clinical-stage biotechnology firm dedicated to advancing immuno-oncology therapies. Their core technology involves engineering T-cells with gene editing to express chimeric antigen…
what is cellectis s.a. · cmvlf stock overview · cellectis s.a. company profile · who is cellectis s.a. ceo · cmvlf OTC · cellectis s.a. headquarters · cellectis s.a. business segments
About Stock Overview & Key Data
Cellectis S.A. (CMVLF) is a Healthcare company in the Biotechnology industry, listed on OTC since Jul 1, 2014. As of the latest trading session, CMVLF stock price is $3.47, with a market capitalization of $251.0M. The stock has returned +177.60% over the past 12 months and -21.14% year-to-date.
According to 10 Wall Street analysts, the consensus rating for Cellectis S.A. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Cellectis S.A. reported revenue of $75.9M and net income of -$70.3M. For detailed data — including Cellectis S.A. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Cellectis S.A. (CMVLF) stock price is $3.47. The stock is traded on OTC under the ticker symbol CMVLF. The 52-week range is $1.25 – $5.04.